Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about GSK
Recent news which mentions GSK
< Previous
1
2
...
24
25
26
27
28
29
30
31
Next >
3 Biotech Stocks That Are too Cheap to Ignore
February 10, 2022
Tickers
GSK
ICPT
LLY
REGN
Tags
Recent Press Releases
Market News
ICPT
From
Motley Fool
Preprint Suggests, Vir-GSK's COVID-19 Antibody Can Evade Omicron Sub-Variant
February 10, 2022
Tickers
GSK
LLY
VIR
Tags
Market News
COVID/19 Coronavirus
Movers
From
Benzinga
Why Are Seagen Shares Sinking Today?
February 10, 2022
Tickers
GSK
MRK
RHHBY
SGEN
Tags
Earnings
Health Care
MRK
From
Benzinga
GlaxoSmithKline: Q4 Earnings Insights
February 09, 2022
Tickers
GSK
Tags
Benzinga
GSK
News
From
Benzinga
Glaxo's Q4 Pharma Sales Jump 20% Boosted By COVID-19 Treatment; Prepares For Spin-Off
February 09, 2022
Tickers
GILD
GSK
UL
Tags
GSK
Guidance
UL
From
Benzinga
Technology stocks lead European markets higher as bond yields continue to ease
February 09, 2022
Tickers
ASML
GSK
Tags
NL:AGN
ASML
NL:ASM
From
MarketWatch
Earnings Scheduled For February 9, 2022
February 09, 2022
Tickers
ACGL
ADN
AEG
AEIS
Tags
IVAC
CPA
CRWS
From
Benzinga
Immunome Shares Seesaw After COVID-19 Antibody Cocktail Works Against Live Omicron Virus
February 08, 2022
Tickers
GSK
IMNM
VIR
Tags
Health Care
VIR
Briefs
From
Benzinga
A Look Into GlaxoSmithKline's Price Over Earnings
February 07, 2022
Tickers
GSK
Tags
Markets
Earnings
Market News
From
Benzinga
‘You will not believe what I’ve just found.’ Inside the ivermectin saga: a hacked password, mysterious websites and faulty data
February 07, 2022
Tickers
GILD
GSK
LLY
MRK
Tags
LLY
CH:ROG
GSK
From
MarketWatch
COVID-19 treatments raked in billions of dollars in 2021. How will they do this year?
February 04, 2022
Tickers
GILD
GSK
LLY
MRK
Tags
VIR
PFE
GILD
From
MarketWatch
Sanofi Records Q4 Topline, Bottomline Growth As Blockbuster Eczema Drug Soars
February 04, 2022
Tickers
GSK
SNY
Tags
Briefs
SNY
Benzinga
From
Benzinga
GSK To Get $1.25B As Settlement For HIV Treatment Drug Patent Row With Gilead
February 02, 2022
Tickers
GILD
GSK
PFE
Tags
News
Biotech
General
From
Benzinga
Gilead earnings slammed by legal settlement, stock falls
February 01, 2022
Tickers
GILD
GSK
PFE
RCUS
Tags
GILD
PFE
GSK
From
MarketWatch
FDA Approves First Injectable For HIV Pre-Exposure Prevention - GSK, Pfizer Backed Treatment
February 01, 2022
Tickers
GSK
PFE
Tags
Health Care
GSK
Briefs
From
Benzinga
Should GlaxoSmithKline Have Accepted Unilever's $68 Billion Consumer Health Offer?
January 28, 2022
Tickers
GSK
PFE
UL
Tags
UL
Market News
Recent Press Releases
From
Motley Fool
10 Stocks to Buy That Could Make You a Millionaire in 2022
January 26, 2022
Tickers
AAN
AMC
ATVI
BKE
Tags
BRK/A
BKE
LRLCY
From
InvestorPlace
Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments
January 25, 2022
Tickers
BNTX
GSK
LLY
MRK
Tags
PFE
GSK
REGN
From
MarketWatch
FDA Clears Lyell Immunopharma' LYL132 Trial For Solid Tumors
January 24, 2022
Tickers
GSK
LYEL
Tags
News
Biotech
Phase 1 Trial
From
Benzinga
Activist investor Nelson Peltz acquires stake in Unilever
January 23, 2022
Tickers
GSK
UL
Tags
UL
GSK
UK:ULVR
From
MarketWatch
Activist Investor Nelson Peltz's Fund Buys Stake In Unilever: FT
January 23, 2022
Tickers
GSK
PG
UL
Tags
Markets
Sector ETFs
Financing
From
Benzinga
Why Jim Cramer Like NextEra Energy And Lincoln Electric?
January 21, 2022
Tickers
AMN
BIRD
GSK
LECO
Tags
Benzinga
SPRO
Small Cap
From
Benzinga
South Africa study shows boosters failed to block omicron, bolstering case for face masks, distancing and hand washing
January 20, 2022
Tickers
BNTX
GILD
GSK
MRK
Tags
GSK
UK:GSK
GILD
From
MarketWatch
Why Unilever Stock Rose as Much as 10% Today
January 19, 2022
Tickers
GSK
UL
Tags
Market News
UL
Recent Press Releases
From
Motley Fool
3 Under-the-Radar COVID Stocks
January 19, 2022
Tickers
ABBV
AMGN
AZN
FIGS
Tags
Market News
FIGS
AMGN
From
Motley Fool
This Defensive Consumer Stock Fell More Than 2 Meme Stock Darlings Today
January 18, 2022
Tickers
AMC
DJI
GME
GSK
Tags
AMC
Recent Press Releases
Market News
From
Motley Fool
23andMe Pivoting To Clinical Research: Could That Lead To A Turnaround For The Stock?
January 18, 2022
Tickers
GOOG
GOOGL
GSK
ME
Tags
genome
GOOG
GOOGL
From
Benzinga
2 Best COVID-19 Growth Stocks to Own in 2022
January 17, 2022
Tickers
GSK
NVAX
VIR
Tags
GSK
Market News
NVAX
From
Motley Fool
GlaxoSmithKline shares soar after Unilever bids for its consumer healthcare unit
January 17, 2022
Tickers
GSK
NVO
PFE
PG
Tags
SNY
PFE
UK:ULVR
From
MarketWatch
GSK Spurns $68.4B Bid From Unilever For Its Consumer Healthcare Business, Opts to Spin-off The Unit
January 15, 2022
Tickers
GSK
PFE
UL
Tags
Benzinga
PFE
General
From
Benzinga
< Previous
1
2
...
24
25
26
27
28
29
30
31
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.